Is the development of a new tuberculosis vaccine possible?
Kaufmann
S H
SH
Dept. of Immunology, Max Planck Institute for Infection Biology, Schumannstr. 21/22, D-10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de
D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000191:economics; D004195:Disease Models, Animal; D014943:Global Health; D018448:Models, Immunological; D009169:Mycobacterium tuberculosis / Q000276:immunology; D013678:Technology, Pharmaceutical / Q000191:economics; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D014944:World Health Organization
D000995:Antitubercular Agents; D001500:BCG Vaccine